Introduction <p>Same-day discharge (SDD) after minimally invasive colorectal surgery has been shown to be safe and associated with reduced opioid use and favorable short-term patient-reported outcomes. However, limited data exist regarding long-term patient perspectives following SDD. During the COVID-19 pandemic, an SDD program incorporating a structured home recovery pathway (HRP) was developed to allow patients to safely undergo surgery with early discharge and remote follow-up.</p> Methods <p>Long-term patient satisfaction and perspectives were assessed using a structured telephone survey. Patients were excluded if they required inpatient admission beyond the day of surgery, were unable to recall participation in the program, or could not be reached. The survey consisted of 20 questions evaluating patient comfort, satisfaction, and perceptions of recovery at home, adapted from previously published short-term SDD questionnaires.</p> Results <p>Fifty-three patients were enrolled in the SDD program, of whom 43 (81%) met criteria for discharge on the day of surgery. Nineteen patients (44%) completed the survey. Twenty (46.5%) were unreachable, 3 (7%) were deceased, and 1 declined participation. Among respondents, the mean comfort level with same-day discharge was 7.4/10, and mean satisfaction with postoperative pain control at home was 8.3/10. Twelve patients (63%) reported they would choose SDD again for a similar procedure, and 15 (78%) stated they would be willing to participate in SDD for other surgeries.</p> Conclusion <p>Patients participating in a SDD program after minimally invasive colorectal surgery report high levels of comfort and satisfaction with home recovery. Structured postoperative support, including preoperative education and routine virtual follow-up, appears to be critical for successful implementation. These findings support the feasibility and patient acceptability of SDD pathways when paired with structured monitoring.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Same-day discharge after colorectal surgery: long-term patient perspectives on safety and feasibility

  • Nathan Aminpour,
  • Akasha B. Vega,
  • Trevor Marshall,
  • Niharika Kareddy,
  • Emma Kar,
  • Elisabeth C. McLemore

摘要

Introduction

Same-day discharge (SDD) after minimally invasive colorectal surgery has been shown to be safe and associated with reduced opioid use and favorable short-term patient-reported outcomes. However, limited data exist regarding long-term patient perspectives following SDD. During the COVID-19 pandemic, an SDD program incorporating a structured home recovery pathway (HRP) was developed to allow patients to safely undergo surgery with early discharge and remote follow-up.

Methods

Long-term patient satisfaction and perspectives were assessed using a structured telephone survey. Patients were excluded if they required inpatient admission beyond the day of surgery, were unable to recall participation in the program, or could not be reached. The survey consisted of 20 questions evaluating patient comfort, satisfaction, and perceptions of recovery at home, adapted from previously published short-term SDD questionnaires.

Results

Fifty-three patients were enrolled in the SDD program, of whom 43 (81%) met criteria for discharge on the day of surgery. Nineteen patients (44%) completed the survey. Twenty (46.5%) were unreachable, 3 (7%) were deceased, and 1 declined participation. Among respondents, the mean comfort level with same-day discharge was 7.4/10, and mean satisfaction with postoperative pain control at home was 8.3/10. Twelve patients (63%) reported they would choose SDD again for a similar procedure, and 15 (78%) stated they would be willing to participate in SDD for other surgeries.

Conclusion

Patients participating in a SDD program after minimally invasive colorectal surgery report high levels of comfort and satisfaction with home recovery. Structured postoperative support, including preoperative education and routine virtual follow-up, appears to be critical for successful implementation. These findings support the feasibility and patient acceptability of SDD pathways when paired with structured monitoring.